Science Videos
from news services

Study Finds Xpansion Interpreter Test Better Predicts Risk of Fragile X Syndrome in Child Birth

Date:
March 21, 2013
Source:
MultiVu / Powered by NewsLook.com
Summary:
Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter can improve the determination of a woman's risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures.
Share:
         
Total shares:  
Related Videos
 

Share This Page:


Health & Medicine News
August 29, 2015

Latest Headlines
updated 12:56 pm ET